FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hing Leung

Research Profile

Disorders

Physiology

Anatomy

Chemicals & Drugs

Procedures

Immunohistochemistry

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Imran Ahmad; Meiling Gao; Rachana Patel; Hing Y Leung
Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis.
Haley L Bennett; Janis T Fleming; Ranadip Mandal; Jim O'Prey; Craig N Robson; Kevin M Ryan; Jacqueline Stockley; Hing Y Leung
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?
Rachana Patel; Taranjit Singh Rai; Owen J Sansom; Morag Seywright; Lukram B Singh; Imran Ahmad; Robert J Barnetson; Joanne Edwards; Janis Fleming; Meiling Gao; Arthur B McKie; Hing Y Leung
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hing Leung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Imran Ahmad; Meiling Gao; Rachana Patel; Hing Y Leung
Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis.
Asian journal of andrology 2013;15(3):323-7.
2013: Haley L Bennett; Janis T Fleming; Ranadip Mandal; Jim O'Prey; Craig N Robson; Kevin M Ryan; Jacqueline Stockley; Hing Y Leung
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?
BJU international 2013;111(4):672-82.
2013: Rachana Patel; Taranjit Singh Rai; Owen J Sansom; Morag Seywright; Lukram B Singh; Imran Ahmad; Robert J Barnetson; Joanne Edwards; Janis Fleming; Meiling Gao; Arthur B McKie; Hing Y Leung
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
The Journal of clinical investigation 2013;123(3):1157-75.
2013: Liz Forbat; Kate Howie; Gill Hubbard; Daniel Kelly; Kenny Boyd; Morag Place; Hing Y Leung
A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing.
BJU international 2013;111(3):389-95.
2013: I Ahmad; D M Berney; C Cooper; J Cuzick; G Fisher; J Fleming; G Kalna; H Møller; P Scardino; L B Singh; Z H Yang; Hing Y Leung
Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer.
British journal of cancer 2013;108(1):149-54.
2013: J M Willder; C E Adams; G Fyffe; S J Heng; P G Horgan; Hing Y Leung; P McCall; M Seywright; C Tannahill; Mark A Underwood; J Edwards
Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.
British journal of cancer 2013;108(1):139-48.
2013: Zichu Yang; Imran Ahmad; Alexander Laird; Ashley Monaghan; Morag Seywright; Hing Y Leung
Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies--are routine investigations for systemic amyloidosis warranted?
Asian journal of andrology 2013;15(1):149-51.
2012: P McCall; C Orange; O J Sansom; M Seywright; Mark A Underwood; I Ahmad; L Bennett; I W G Forbes; Hing Y Leung; L M Mackenzie; Joanne Edwards
NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression.
British journal of cancer 2012;107(9):1554-63.
2012: Meiling Gao; Imran Ahmad; Joanne Edwards; Janis Fleming; Stuart McCracken; Jim Norman; Rachana Patel; Kanagasabai Sahadevan; Owen Sansom; Morag Seywright; Hing Y Leung
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis.
EMBO molecular medicine 2012;4(8):776-90.
2012: Imran Ahmad; Owen J Sansom; Hing Y Leung
Exploring molecular genetics of bladder cancer: lessons learned from mouse models.
Disease models & mechanisms 2012;5(3):323-32.
2012: Imran Ahmad; Tomoko Iwata; Hing Y Leung
Mechanisms of FGFR-mediated carcinogenesis.
Biochimica et biophysica acta 2012;1823(4):850-60.
2012: Stuart C Williamson; Laura Wilson; Kelly Coffey; Anastasia C Hepburn; Hing Y Leung; Deepali Pal; Craig N Robson; Claudia A Ryan-Munden; Rakesh Heer
Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
PloS one 2012;7(11):e48944.
2012: John D Kelly; Hing Y Leung; Odu Okoturo; Robert S Pickard; A Toby Prevost; Teresa Prevost; Wendy Robson; Fiona Tulloch; Joana C Vasconcelos; Nikhil Vasdev; Gareth H Williams; Alex Wollenschlaeger; Keith Burling; Tim J Dudderidge; Ian Halsall; Kai Stoeber
Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.
PloS one 2012;7(7):e40305.
2012: Aswini Krishnan; James Wilson; Hing Y Leung
Approaches for developing novel microtubule targeting agents (MTAs) for therapeutic exploitation.
Current pharmaceutical design 2012;18(19):2804-10.
2012: Rachana Patel; Hing Y Leung
Targeting the EGFR-family for therapy: biological challenges and clinical perspective.
Current pharmaceutical design 2012;18(19):2672-9.
2011: Imran Ahmad; Robert J Barnetson; Valerie G Brunton; Joanne Edwards; William J Muller; Colin Nixon; Rachana Patel; Owen J Sansom; Morag Seywright; Lukram Babloo Singh; Hing Y Leung
HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(39):16392-7.
2011: Luis R de Brito; Andrew G Hall; Mike A Batey; Graham Jackson; Hing Y Leung; Helen Maitland; David R Newell; Matt S Squires; Yan Zhao; Julie A E Irving
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma.
Leukemia research 2011;35(9):1233-40.
2011: Imran Ahmad; Mona Foth; Hing Y Leung; Carol-Ann Morris; Owen J Sansom; Lukram Babloo Singh; Makoto Mark Taketo; Xue-Ru Wu; Tomoko Iwata
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
Disease models & mechanisms 2011;4(4):548-55.
2011: A K Ramsay; S R C McCracken; M Soofi; J Fleming; A X Yu; I Ahmad; R Morland; Laura M Machesky; Colin Nixon; D R Edwards; R K Nuttall; M Seywright; R Marquez; Evan T Keller; Hing Y Leung
ERK5 signalling in prostate cancer promotes an invasive phenotype.
British journal of cancer 2011;104(4):664-72.
2011: I Ahmad; Jennifer P Morton; L B Singh; S M Radulescu; R A Ridgway; S Patel; J Woodgett; D J Winton; M M Taketo; X-R Wu; Hing Y Leung; Owen J Sansom
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.
Oncogene 2011;30(2):178-89.
2011: Fadhel S Shaheen; Pawel Znojek; Ann Fisher; Martin Webster; Ruth Plummer; Luke Gaughan; Graeme C M Smith; Hing Y Leung; Nicola J Curtin; Craig N Robson
Targeting the DNA double strand break repair machinery in prostate cancer.
PloS one 2011;6(5):e20311.
2011: Shaun S Tan; Imran Ahmad; Haley L Bennett; Lukram Singh; Colin Nixon; Morag Seywright; Robert J Barnetson; Joanne Edwards; Hing Y Leung
GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.
The Journal of pathology 2011;223(1):81-7.
2010: Rakesh Heer; Nick Clarke; Anastasia C Rigas; Timothy R Cheek; Robert Pickard; Hing Y Leung
Phenotypic modulation of human urinary tract stroma-derived fibroblasts by transforming growth factor beta3.
Urology 2010;76(2):509.e13-20.
2010: Carolyn Wiltshire; Babloo L Singh; Jacqueline Stockley; Janis Fleming; Brendan Doyle; Robert Barnetson; Craig N Robson; Frank Kozielski; Hing Y Leung
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
Molecular cancer therapeutics 2010;9(6):1730-9.
2009: S Darby; T Murphy; H Thomas; C N Robson; Hing Y Leung; M E Mathers; V J Gnanapragasam
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
British journal of cancer 2009;101(11):1891-9.
2009: Alison K Ramsay; Hing Y Leung
Signalling pathways in prostate carcinogenesis: potentials for molecular-targeted therapy.
Clinical science (London, England : 1979) 2009;117(6):209-28.
2009: Imran Ahmad; Owen J Sansom; Hing Y Leung
The role of murine models of prostate cancer in drug target discovery and validation.
Expert opinion on drug discovery 2009;4(8):879-88.
2009: Phillippa J Carling; David J Elliott; Craig N Robson; Hing Y Leung; Prabhakar Rajan
Targeting alternative splicing in prostate oncology.
Discovery medicine 2009;8(41):74-80.
2009: Prabhakar Rajan; David J Elliott; Craig N Robson; Hing Y Leung
Alternative splicing and biological heterogeneity in prostate cancer.
Nature reviews. Urology 2009;6(8):454-60.
2009: Oleg Tatarov; Thomas J Mitchell; Morag Seywright; Hing Y Leung; Valerie G Brunton; Joanne Edwards
SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3540-9.
2009: Prabhakar Rajan; Caroline Dalgliesh; Cyril F Bourgeois; Monika Heiner; kaveh emami; Emma L Clark; Albrecht Bindereif; James Stevenin; Craig N Robson; Hing Y Leung; David J Elliott
Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies.
BMC cell biology 2009;10():82.
2008: Emma L Clark; Anne Coulson; Caroline Dalgliesh; Prabhakar Rajan; Samantha M Nicol; Stewart Fleming; Rakesh Heer; Luke Gaughan; Hing Y Leung; David J Elliott; Frances V Fuller-Pace; Craig N Robson
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
Cancer research 2008;68(19):7938-46.
2008: Lynsey Rogerson; S Darby; Talal Jabbar; Marie E Mathers; Hing Y Leung; Craig N Robson; Kanagasabai Sahadevan; Kieran O'Toole; Vincent J Gnanapragasam
Application of transcript profiling in formalin-fixed paraffin-embedded diagnostic prostate cancer needle biopsies.
BJU international 2008;102(3):364-70.
2008: Prabhakar Rajan; Luke Gaughan; Caroline Dalgliesh; Amira El-Sherif; Craig N Robson; Hing Y Leung; David J Elliott
Regulation of gene expression by the RNA-binding protein Sam68 in cancer.
Biochemical Society transactions 2008;36(Pt 3):505-7.
2008: S R C McCracken; A Ramsay; Rakesh Heer; Marie E Mathers; B L Jenkins; J Edwards; Craig N Robson; R Marquez; P Cohen; Hing Y Leung
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.
Oncogene 2008;27(21):2978-88.
2008: P Rajan; Luke Gaughan; Caroline Dalgliesh; A El-Sherif; Craig N Robson; Hing Y Leung; David J Elliott
The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor.
The Journal of pathology 2008;215(1):67-77.
2008: Imran Ahmad; Owen J Sansom; Hing Y Leung
Advances in mouse models of prostate cancer.
Expert reviews in molecular medicine 2008;10():e16.
2007: Joanne Edwards; Hing Y Leung
Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
European urology 2007;52(6):1680-1.
2007: S Darby; J Stockley; MM Khan; Craig N Robson; Hing Y Leung; Vincent J Gnanapragasam
Expression of GnRH type II is regulated by the androgen receptor in prostate cancer.
Endocrine-related cancer 2007;14(3):613-24.
2007: K Sahadevan; S Darby; Hing Y Leung; Marie E Mathers; Craig N Robson; Vincent J Gnanapragasam
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
The Journal of pathology 2007;213(1):82-90.
2007: Rakesh Heer; Craig N Robson; Brian K Shenton; Hing Y Leung
The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
Journal of cellular physiology 2007;212(3):572-8.
2007: Tim J Dudderidge; S R McCracken; Marco Loddo; Thomas Fanshawe; J D Kelly; D E Neal; Hing Y Leung; Gareth H Williams; Kai Stoeber
Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
British journal of cancer 2007;96(9):1384-93.
2007: David Jamieson; Kerrie Wilson; Simon Pridgeon; Jane P Margetts; Richard J Edmondson; Hing Y Leung; Richard Knox; Alan V Boddy
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1584-90.
2007: John G Rowland; Joanne L Robson; William J Simon; Hing Y Leung; Antoni R Slabas
Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells.
Proteomics 2007;7(1):47-63.
2006: Ting Ling Lo; Chee Wai Fong; Permeen Yusoff; Arthur Bennett McKie; Mei-Sze Chua; Hing Y Leung; Graeme R Guy
Sprouty and cancer: the first terms report.
Cancer letters 2006;242(2):141-50.
2006: Ian R Logan; Luke Gaughan; Stuart R C McCracken; Vasileia Sapountzi; Hing Y Leung; Craig N Robson
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.
Molecular and cellular biology 2006;26(17):6502-10.
2006: Kelly Armstrong; Craig N Robson; Hing Y Leung
NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells.
The Prostate 2006;66(11):1223-34.
2006: S Darby; K Sahadevan; MM Khan; Craig N Robson; Hing Y Leung; Vincent J Gnanapragasam
Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer.
Oncogene 2006;25(29):4122-7.
2006: Vincent J Gnanapragasam; Vinod Kumar; David Langton; Robert S Pickard; Hing Y Leung
Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 2006;13(6):711-5.
2006: Aaron Leiblich; Simon Cross; james catto; J T Phillips; Hing Y Leung; Freddie C Hamdy; Ishtiaq Rehman
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
Oncogene 2006;25(20):2953-60.
2006: Rakesh Heer; Anne T Collins; Craig N Robson; Brian K Shenton; Hing Y Leung
KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium.
Journal of cell science 2006;119(Pt 7):1416-24.
2006: Islay A Steele; Richard J Edmondson; Hing Y Leung; Barry R Davies
Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.
Growth factors (Chur, Switzerland) 2006;24(1):45-53.
2006: Chee Wai Fong; Mei-Sze Chua; Arthur Bennett McKie; Sharon Hee Ming Ling; Veronica Mason; Rui Li; Permeen Yusoff; Ting Ling Lo; Hing Y Leung; Samuel K S So; Graeme R Guy
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.
Cancer research 2006;66(4):2048-58.
2005: César Fernández-Sánchez; Calum J McNeil; Keith Rawson; Olle Nilsson; Hing Y Leung; Vincent J Gnanapragasam
One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
Journal of immunological methods 2005;307(1-2):1-12.
2005: Ishtiaq Rehman; Simon Cross; james catto; Aaron Leiblich; Abir Mukherjee; Abdel-Rahmène Azzouzi; Hing Y Leung; Freddie C Hamdy
Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
The Prostate 2005;65(4):322-30.
2005: Vincent J Gnanapragasam; S Darby; MM Khan; W G Lock; Craig N Robson; Hing Y Leung
Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
The Journal of pathology 2005;206(2):205-13.
2005: Arthur Bennett McKie; David A Douglas; Sharon Olijslagers; Julia Graham; Mahmoud M Omar; Rakesh Heer; Vincent J Gnanapragasam; Craig N Robson; Hing Y Leung
Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer.
Oncogene 2005;24(13):2166-74.
2005: Bharat Gowardhan; D A Douglas; Marie E Mathers; Arthur Bennett McKie; S R C McCracken; Craig N Robson; Hing Y Leung
Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.
British journal of cancer 2005;92(2):320-7.
2004: Rakesh Heer; D Douglas; Marie E Mathers; Craig N Robson; Hing Y Leung
Fibroblast growth factor 17 is over-expressed in human prostate cancer.
The Journal of pathology 2004;204(5):578-86.
2004: Hanneng Zhu; Michal Mazor; Yoshiaki Kawano; Marjorie M Walker; Hing Y Leung; Kelly Armstrong; Jonathan Waxman; Robert Kypta
Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
Cancer research 2004;64(21):7918-26.
2004: Bharat Gowardhan; Alaiyi F West; Craig N Robson; Hing Y Leung
Adenovirus-mediated expression of a soluble fibroblast growth factor receptor inhibits in vitro growth of prostate DU145 cells.
The Prostate 2004;61(1):50-9.
2004: Kalipso Halkidou; Luke Gaughan; Susan Cook; Hing Y Leung; David E Neal; Craig N Robson
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer.
The Prostate 2004;59(2):177-89.
2004: Kalipso Halkidou; Susan Cook; Hing Y Leung; David E Neal; Craig N Robson
Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate.
European urology 2004;45(3):382-9; author reply 389.
2003: Vincent J Gnanapragasam; Mary C Robinson; Colin Marsh; Craig N Robson; Freddie C Hamdy; Hing Y Leung
FGF8 isoform b expression in human prostate cancer.
British journal of cancer 2003;88(9):1432-8.
2003: Kalipso Halkidou; Vincent J Gnanapragasam; Piyush B Mehta; Ian R Logan; Mark E Brady; Susan Cook; Hing Y Leung; David E Neal; Craig N Robson
Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development.
Oncogene 2003;22(16):2466-77.
2003: Marcus J Drake; W Robson; P Mehta; I Schofield; David E Neal; Hing Y Leung
An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
British journal of cancer 2003;88(6):822-7.
2003: Piyush B Mehta; B L Jenkins; L McCarthy; L Thilak; Craig N Robson; David E Neal; Hing Y Leung
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
Oncogene 2003;22(9):1381-9.
2002: Vincent J Gnanapragasam; Craig N Robson; David E Neal; Hing Y Leung
Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Oncogene 2002;21(33):5069-80.
2002: Bharat Gowardhan; I Pedley; Mary C Robinson; Hing Y Leung
Late onset classical seminoma in a sib pair with possible familial aetiology.
Scandinavian journal of urology and nephrology 2002;36(5):383-4.
2001: Vincent J Gnanapragasam; Hing Y Leung; A S Pulimood; David E Neal; Craig N Robson
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
British journal of cancer 2001;85(12):1928-36.
2001: Islay A Steele; Richard J Edmondson; Judith N Bulmer; B S Bolger; Hing Y Leung; Barry R Davies
Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer.
Oncogene 2001;20(41):5878-87.
2001: Piyush B Mehta; Craig N Robson; David E Neal; Hing Y Leung
Keratinocyte growth factor activates p38 MAPK to induce stress fibre formation in human prostate DU145 cells.
Oncogene 2001;20(38):5359-65.
2001: Alaiyi F West; M O'Donnell; R G Charlton; David E Neal; Hing Y Leung
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
British journal of cancer 2001;85(4):576-83.
2000: Vincent J Gnanapragasam; Craig N Robson; Hing Y Leung; David E Neal
Androgen receptor signalling in the prostate.
BJU international 2000;86(9):1001-13.
2000: Piyush B Mehta; Craig N Robson; David E Neal; Hing Y Leung
Serum keratinocyte growth factor measurement in patients with prostate cancer.
The Journal of urology 2000;164(6):2151-5.
2000: P Mehta; Craig N Robson; David E Neal; Hing Y Leung
Fibroblast growth factor receptor-2 mutation analysis in human prostate cancer.
BJU international 2000;86(6):681-5.
2000: D E Neal; Hing Y Leung; P H Powell; Freddie C Hamdy; Jenny Donovan
Unanswered questions in screening for prostate cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(10):1316-21.
2000: Alaiyi F West; Hing Y Leung; P H Powell
Epididymectomy is an effective treatment for scrotal pain after vasectomy.
BJU international 2000;85(9):1097-9.
1999: TJ Dorkin; Mary C Robinson; Colin Marsh; David E Neal; Hing Y Leung
aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8.
The Journal of pathology 1999;189(4):564-9.
1999: Alaiyi F West; Hing Y Leung; P H Powell
Pan-urethral warts as a cause of acute retention of urine.
BJU international 1999;84(9):1100-1.
1999: TJ Dorkin; Mary C Robinson; Colin Marsh; A Bjartell; David E Neal; Hing Y Leung
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease.
Oncogene 1999;18(17):2755-61.
1998: James N'Dow; Hing Y Leung; C Marshall; David E Neal
Bowel dysfunction after bladder reconstruction.
The Journal of urology 1998;159(5):1470-4; discussion 1474-5.
1997: Hing Y Leung; P Mehta; L B Gray; Anne T Collins; Craig N Robson; David E Neal
Keratinocyte growth factor expression in hormone insensitive prostate cancer.
Oncogene 1997;15(9):1115-20.
1997: Arthur Bennett McKie; T Iwamura; Hing Y Leung; M A Hollingsworth; Nick Lemoine
Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis.
Genes, chromosomes & cancer 1997;18(1):30-41.
1996: Hing Y Leung; T R Griffiths; David E Neal
Bladder cancer.
Postgraduate medical journal 1996;72(854):719-24.
1996: Hing Y Leung; C Dickson; Craig N Robson; David E Neal
Over-expression of fibroblast growth factor-8 in human prostate cancer.
Oncogene 1996;12(8):1833-5.
1996: Hing Y Leung; M Davis; D Arnold; Freddie C Hamdy; David E Neal
The role of the nurse practitioner in a urology service.
British journal of urology 1996;77(4):502-5.